Apart from being a candidate for the study acronym of the year: Odense Pharmacist Trial Investigating Medication Interventions at Sector Transfer (OPTIMIST), this study, published recently in one of the world’s most prestigious medical journals, confirms what is intuitive – for patients with polypharmacy, pharmacist-led medication reviews reduced readmission to hospital at endpoints 30 days and 180 days after the intervention. The implications for patient care and in financial terms appear to be stark, and can’t be ignored by clinicians, health economists or consumers – more at https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2670037